Bair Teresa Brophy Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
3
Insider Sells Sum
$151,775.97

Insider Activity of Bair Teresa Brophy

According to the SEC Form 4 filings, Bair Teresa Brophy, being in a position of

  1. Chief Legal Officer at Kura Oncology, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 62197 shares for $700,688,
    over all time since 2024-01-29, has bought 0 shares, and sold 84510 shares for $940,492.

Biography of Bair Teresa Brophy

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $700,6885100

Comparison of Insiders on Amount of Buys and Sells

2026-09-28SaleKura Oncology, Inc.
KURA
Chief Legal Officer
8,442
0.0094%
$10.50$88,618-4.62%
2026-08-19SaleKura Oncology, Inc.
KURA
Chief Legal Officer
31,487
0.0358%
$12.63$397,681-14.13%
2026-05-18SaleKura Oncology, Inc.
KURA
Chief Legal Officer
2,256
0.0026%
$9.38$21,160+15.22%
2026-01-27SaleKura Oncology, Inc.
KURA
Chief Legal Officer
11,208
0.0129%
$8.46$94,828+12.99%
2025-11-14SaleKura Oncology, Inc.
KURA
Chief Legal Officer
8,804
0.0106%
$11.18$98,401-12.71%
2025-09-29SaleKura Oncology, Inc.
KURA
Chief Legal Officer
8,805
0.0101%
$8.94$78,736+9.03%
2025-05-19SaleKura Oncology, Inc.
KURA
Chief Legal Officer
1,559
0.0017%
$5.96$9,292+37.5%
2025-01-28SaleKura Oncology, Inc.
KURA
Chief Legal Officer
7,281
0.0094%
$7.87$57,315+0.9%
2024-05-20SaleKura Oncology, Inc.
KURA
Chief Legal Officer
2,615
0.0034%
$22.15$57,916-28.06%
2024-01-29SaleKura Oncology, Inc.
KURA
Chief Legal Officer
2,053
0.0027%
$17.80$36,544+7.47%
Total: 10
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.